Search Results

You are looking at 1 - 10 of 956 items for :

  • prostate cancer x
  • Refine by access: Content accessible to me x
Clear All
Adam W Nelson Cancer Research UK Cambridge Institute, University of Cambridge, Robinson Way, Cambridge CB2 0RE, UK

Department of Urology Addenbrooke's Hospital, Cambridge University Hospitals NHS Foundation Trust, Cambridge CB2 0QQ, UK

Dame Roma Mitchell Cancer Research Laboratories Faculty of Health Sciences, School of Medicine, The University of Adelaide, Level 4, Hanson Institute Building, DX Number 650 801, Adelaide, South Australia 5000, Australia

Department of Oncology University of Cambridge, Cambridge CB2 2QQ, UK
Cancer Research UK Cambridge Institute, University of Cambridge, Robinson Way, Cambridge CB2 0RE, UK

Department of Urology Addenbrooke's Hospital, Cambridge University Hospitals NHS Foundation Trust, Cambridge CB2 0QQ, UK

Dame Roma Mitchell Cancer Research Laboratories Faculty of Health Sciences, School of Medicine, The University of Adelaide, Level 4, Hanson Institute Building, DX Number 650 801, Adelaide, South Australia 5000, Australia

Department of Oncology University of Cambridge, Cambridge CB2 2QQ, UK

Search for other papers by Adam W Nelson in
Google Scholar
PubMed
Close
,
Wayne D Tilley Cancer Research UK Cambridge Institute, University of Cambridge, Robinson Way, Cambridge CB2 0RE, UK

Department of Urology Addenbrooke's Hospital, Cambridge University Hospitals NHS Foundation Trust, Cambridge CB2 0QQ, UK

Dame Roma Mitchell Cancer Research Laboratories Faculty of Health Sciences, School of Medicine, The University of Adelaide, Level 4, Hanson Institute Building, DX Number 650 801, Adelaide, South Australia 5000, Australia

Department of Oncology University of Cambridge, Cambridge CB2 2QQ, UK
Cancer Research UK Cambridge Institute, University of Cambridge, Robinson Way, Cambridge CB2 0RE, UK

Department of Urology Addenbrooke's Hospital, Cambridge University Hospitals NHS Foundation Trust, Cambridge CB2 0QQ, UK

Dame Roma Mitchell Cancer Research Laboratories Faculty of Health Sciences, School of Medicine, The University of Adelaide, Level 4, Hanson Institute Building, DX Number 650 801, Adelaide, South Australia 5000, Australia

Department of Oncology University of Cambridge, Cambridge CB2 2QQ, UK

Search for other papers by Wayne D Tilley in
Google Scholar
PubMed
Close
,
David E Neal Cancer Research UK Cambridge Institute, University of Cambridge, Robinson Way, Cambridge CB2 0RE, UK

Department of Urology Addenbrooke's Hospital, Cambridge University Hospitals NHS Foundation Trust, Cambridge CB2 0QQ, UK

Dame Roma Mitchell Cancer Research Laboratories Faculty of Health Sciences, School of Medicine, The University of Adelaide, Level 4, Hanson Institute Building, DX Number 650 801, Adelaide, South Australia 5000, Australia

Department of Oncology University of Cambridge, Cambridge CB2 2QQ, UK
Cancer Research UK Cambridge Institute, University of Cambridge, Robinson Way, Cambridge CB2 0RE, UK

Department of Urology Addenbrooke's Hospital, Cambridge University Hospitals NHS Foundation Trust, Cambridge CB2 0QQ, UK

Dame Roma Mitchell Cancer Research Laboratories Faculty of Health Sciences, School of Medicine, The University of Adelaide, Level 4, Hanson Institute Building, DX Number 650 801, Adelaide, South Australia 5000, Australia

Department of Oncology University of Cambridge, Cambridge CB2 2QQ, UK
Cancer Research UK Cambridge Institute, University of Cambridge, Robinson Way, Cambridge CB2 0RE, UK

Department of Urology Addenbrooke's Hospital, Cambridge University Hospitals NHS Foundation Trust, Cambridge CB2 0QQ, UK

Dame Roma Mitchell Cancer Research Laboratories Faculty of Health Sciences, School of Medicine, The University of Adelaide, Level 4, Hanson Institute Building, DX Number 650 801, Adelaide, South Australia 5000, Australia

Department of Oncology University of Cambridge, Cambridge CB2 2QQ, UK

Search for other papers by David E Neal in
Google Scholar
PubMed
Close
, and
Jason S Carroll Cancer Research UK Cambridge Institute, University of Cambridge, Robinson Way, Cambridge CB2 0RE, UK

Department of Urology Addenbrooke's Hospital, Cambridge University Hospitals NHS Foundation Trust, Cambridge CB2 0QQ, UK

Dame Roma Mitchell Cancer Research Laboratories Faculty of Health Sciences, School of Medicine, The University of Adelaide, Level 4, Hanson Institute Building, DX Number 650 801, Adelaide, South Australia 5000, Australia

Department of Oncology University of Cambridge, Cambridge CB2 2QQ, UK
Cancer Research UK Cambridge Institute, University of Cambridge, Robinson Way, Cambridge CB2 0RE, UK

Department of Urology Addenbrooke's Hospital, Cambridge University Hospitals NHS Foundation Trust, Cambridge CB2 0QQ, UK

Dame Roma Mitchell Cancer Research Laboratories Faculty of Health Sciences, School of Medicine, The University of Adelaide, Level 4, Hanson Institute Building, DX Number 650 801, Adelaide, South Australia 5000, Australia

Department of Oncology University of Cambridge, Cambridge CB2 2QQ, UK

Search for other papers by Jason S Carroll in
Google Scholar
PubMed
Close

Introduction Prostate cancer is the commonest, non-cutaneous cancer in men, affecting 214 per 1000 European men. It is the second commonest cause of cancer death, accounting for 15% of all male cancers in developed countries ( Heidenreich et al

Free access
Matias Knuuttila Research Centre for Integrative Physiology and Pharmacology, Institute of Biomedicine, University of Turku, Turku, Finland
Turku Center for Disease Modeling (TCDM), Institute of Biomedicine, University of Turku, Turku, Finland

Search for other papers by Matias Knuuttila in
Google Scholar
PubMed
Close
,
Arfa Mehmood Turku Centre for Biotechnology, University of Turku and Åbo Akademi University, Turku, Finland

Search for other papers by Arfa Mehmood in
Google Scholar
PubMed
Close
,
Jenni Mäki-Jouppila Research Centre for Integrative Physiology and Pharmacology, Institute of Biomedicine, University of Turku, Turku, Finland
Turku Center for Disease Modeling (TCDM), Institute of Biomedicine, University of Turku, Turku, Finland

Search for other papers by Jenni Mäki-Jouppila in
Google Scholar
PubMed
Close
,
Henrik Ryberg Center for Bone and Arthitis Research, The Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden

Search for other papers by Henrik Ryberg in
Google Scholar
PubMed
Close
,
Pekka Taimen Department of Pathology, University of Turku and Turku University Hospital, Turku, Finland

Search for other papers by Pekka Taimen in
Google Scholar
PubMed
Close
,
Juha Knaapila Department of Urology, Turku University Hospital, Turku, Finland

Search for other papers by Juha Knaapila in
Google Scholar
PubMed
Close
,
Otto Ettala Department of Urology, Turku University Hospital, Turku, Finland

Search for other papers by Otto Ettala in
Google Scholar
PubMed
Close
,
Peter J Boström Department of Urology, Turku University Hospital, Turku, Finland

Search for other papers by Peter J Boström in
Google Scholar
PubMed
Close
,
Claes Ohlsson Center for Bone and Arthitis Research, The Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden

Search for other papers by Claes Ohlsson in
Google Scholar
PubMed
Close
,
Mikko S Venäläinen Turku Centre for Biotechnology, University of Turku and Åbo Akademi University, Turku, Finland

Search for other papers by Mikko S Venäläinen in
Google Scholar
PubMed
Close
,
Asta Laiho Turku Centre for Biotechnology, University of Turku and Åbo Akademi University, Turku, Finland

Search for other papers by Asta Laiho in
Google Scholar
PubMed
Close
,
Laura L Elo Turku Centre for Biotechnology, University of Turku and Åbo Akademi University, Turku, Finland

Search for other papers by Laura L Elo in
Google Scholar
PubMed
Close
,
Petra Sipilä Research Centre for Integrative Physiology and Pharmacology, Institute of Biomedicine, University of Turku, Turku, Finland
Turku Center for Disease Modeling (TCDM), Institute of Biomedicine, University of Turku, Turku, Finland

Search for other papers by Petra Sipilä in
Google Scholar
PubMed
Close
,
Sari I Mäkelä Turku Center for Disease Modeling (TCDM), Institute of Biomedicine, University of Turku, Turku, Finland
Functional Foods Forum, University of Turku, Turku, Finland

Search for other papers by Sari I Mäkelä in
Google Scholar
PubMed
Close
, and
Matti Poutanen Research Centre for Integrative Physiology and Pharmacology, Institute of Biomedicine, University of Turku, Turku, Finland
Turku Center for Disease Modeling (TCDM), Institute of Biomedicine, University of Turku, Turku, Finland
Center for Bone and Arthitis Research, The Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden

Search for other papers by Matti Poutanen in
Google Scholar
PubMed
Close

Introduction Androgens play a crucial role in the normal development and growth of the prostate and the growth of prostate cancer. The prostate tissue is known for the local biosynthesis of dihydrotestosterone (DHT), which is the principal

Free access
Joanna M Day
Search for other papers by Joanna M Day in
Google Scholar
PubMed
Close
,
Paul A Foster Oncology Drug Discovery and Women's Health Group, School of Clinical and Experimental Medicine, IPSEN, Medicinal Chemistry, Division of Diabetes, Endocrinology and Metabolism, and Sterix Ltd., Imperial College London, London W12 0NN, UK

Search for other papers by Paul A Foster in
Google Scholar
PubMed
Close
,
Helena J Tutill
Search for other papers by Helena J Tutill in
Google Scholar
PubMed
Close
,
Fabien Schmidlin Oncology Drug Discovery and Women's Health Group, School of Clinical and Experimental Medicine, IPSEN, Medicinal Chemistry, Division of Diabetes, Endocrinology and Metabolism, and Sterix Ltd., Imperial College London, London W12 0NN, UK

Search for other papers by Fabien Schmidlin in
Google Scholar
PubMed
Close
,
Christopher M Sharland Oncology Drug Discovery and Women's Health Group, School of Clinical and Experimental Medicine, IPSEN, Medicinal Chemistry, Division of Diabetes, Endocrinology and Metabolism, and Sterix Ltd., Imperial College London, London W12 0NN, UK

Search for other papers by Christopher M Sharland in
Google Scholar
PubMed
Close
,
Jonathan D Hargrave Oncology Drug Discovery and Women's Health Group, School of Clinical and Experimental Medicine, IPSEN, Medicinal Chemistry, Division of Diabetes, Endocrinology and Metabolism, and Sterix Ltd., Imperial College London, London W12 0NN, UK

Search for other papers by Jonathan D Hargrave in
Google Scholar
PubMed
Close
,
Nigel Vicker Oncology Drug Discovery and Women's Health Group, School of Clinical and Experimental Medicine, IPSEN, Medicinal Chemistry, Division of Diabetes, Endocrinology and Metabolism, and Sterix Ltd., Imperial College London, London W12 0NN, UK

Search for other papers by Nigel Vicker in
Google Scholar
PubMed
Close
,
Barry V L Potter Oncology Drug Discovery and Women's Health Group, School of Clinical and Experimental Medicine, IPSEN, Medicinal Chemistry, Division of Diabetes, Endocrinology and Metabolism, and Sterix Ltd., Imperial College London, London W12 0NN, UK

Search for other papers by Barry V L Potter in
Google Scholar
PubMed
Close
,
Michael J Reed
Search for other papers by Michael J Reed in
Google Scholar
PubMed
Close
, and
Atul Purohit
Search for other papers by Atul Purohit in
Google Scholar
PubMed
Close

Introduction Treatment of hormone-dependent prostate cancer by androgen ablation is usually initially successful, reducing primary tumour burden and increasing 5-year survival rates. Currently, androgen ablation is achieved using orchidectomy

Free access
Luke A Selth Dame Roma Mitchell Cancer Research Laboratories and Adelaide Prostate Cancer Research Centre, University of Adelaide and Hanson Institute, Adelaide 5000, Australia

Search for other papers by Luke A Selth in
Google Scholar
PubMed
Close
,
Wayne D Tilley Dame Roma Mitchell Cancer Research Laboratories and Adelaide Prostate Cancer Research Centre, University of Adelaide and Hanson Institute, Adelaide 5000, Australia

Search for other papers by Wayne D Tilley in
Google Scholar
PubMed
Close
, and
Lisa M Butler Dame Roma Mitchell Cancer Research Laboratories and Adelaide Prostate Cancer Research Centre, University of Adelaide and Hanson Institute, Adelaide 5000, Australia

Search for other papers by Lisa M Butler in
Google Scholar
PubMed
Close

in prostate cancer (PCa), thyroid cancer, neuroblastoma, and glioblastoma but acts as a tumor suppressor in ovarian and breast cancer (for review, see Cortez et al . (2011) ). Such dichotomy in respect to miRNA function in cancer is not uncommon and

Free access
T M Murphy Prostate Cancer Research Group, Institute of Molecular Medicine, Trinity College Dublin, Ireland

Search for other papers by T M Murphy in
Google Scholar
PubMed
Close
,
A S Perry Prostate Cancer Research Group, Institute of Molecular Medicine, Trinity College Dublin, Ireland

Search for other papers by A S Perry in
Google Scholar
PubMed
Close
, and
M Lawler Prostate Cancer Research Group, Institute of Molecular Medicine, Trinity College Dublin, Ireland

Search for other papers by M Lawler in
Google Scholar
PubMed
Close

Introduction Prostate cancer represents a global public health problem. Worldwide, it is the second most common noncutaneous cancer in men, accounting for ∼10% of male cancers ( Parkin et al . 2005 ). Prostate cancer is the second leading cause of

Free access
Renea A Taylor Prostate and Breast Cancer Research Group, Department of Anatomy and Developmental Biology, Monash University, Clayton, Victoria 3800, Australia

Search for other papers by Renea A Taylor in
Google Scholar
PubMed
Close
,
Roxanne Toivanen Prostate and Breast Cancer Research Group, Department of Anatomy and Developmental Biology, Monash University, Clayton, Victoria 3800, Australia

Search for other papers by Roxanne Toivanen in
Google Scholar
PubMed
Close
, and
Gail P Risbridger Prostate and Breast Cancer Research Group, Department of Anatomy and Developmental Biology, Monash University, Clayton, Victoria 3800, Australia

Search for other papers by Gail P Risbridger in
Google Scholar
PubMed
Close

Introduction Prostate cancer is a major cause of morbidity and mortality in men around the world, being the most common solid tumor. In America, ∼6 out of every 50 men over the age of 50 will be diagnosed with prostate cancer in his lifetime. In

Free access
Suresh Veeramani
Search for other papers by Suresh Veeramani in
Google Scholar
PubMed
Close
,
Ta-Chun Yuan
Search for other papers by Ta-Chun Yuan in
Google Scholar
PubMed
Close
,
Siu-Ju Chen
Search for other papers by Siu-Ju Chen in
Google Scholar
PubMed
Close
,
Fen-Fen Lin
Search for other papers by Fen-Fen Lin in
Google Scholar
PubMed
Close
,
Juliette E Petersen
Search for other papers by Juliette E Petersen in
Google Scholar
PubMed
Close
,
Syed Shaheduzzaman
Search for other papers by Syed Shaheduzzaman in
Google Scholar
PubMed
Close
,
Shiv Srivastava
Search for other papers by Shiv Srivastava in
Google Scholar
PubMed
Close
,
Richard G MacDonald
Search for other papers by Richard G MacDonald in
Google Scholar
PubMed
Close
, and
Ming-Fong Lin
Search for other papers by Ming-Fong Lin in
Google Scholar
PubMed
Close

PAcP is a 100 kDa glycoprotein containing two subunits of approximately 50 kDa each. In the mid 1930s, Gutman and his colleagues made the noteworthy observation that the activity of PAcP is increased in the circulation of patients with prostate cancer

Free access
Amy A Lubik Institute of Health and Biomedical Innovation, Vancouver Prostate Centre, Departments of Medicine and Oncology, Australian Prostate Cancer Research Centre – Queensland, Princess Alexandra Hospital, Queensland University of Technology, Level 1, Building 1, 199 Ipswich Road, Brisbane, Queensland 4102, Australia
Institute of Health and Biomedical Innovation, Vancouver Prostate Centre, Departments of Medicine and Oncology, Australian Prostate Cancer Research Centre – Queensland, Princess Alexandra Hospital, Queensland University of Technology, Level 1, Building 1, 199 Ipswich Road, Brisbane, Queensland 4102, Australia

Search for other papers by Amy A Lubik in
Google Scholar
PubMed
Close
,
Jennifer H Gunter Institute of Health and Biomedical Innovation, Vancouver Prostate Centre, Departments of Medicine and Oncology, Australian Prostate Cancer Research Centre – Queensland, Princess Alexandra Hospital, Queensland University of Technology, Level 1, Building 1, 199 Ipswich Road, Brisbane, Queensland 4102, Australia

Search for other papers by Jennifer H Gunter in
Google Scholar
PubMed
Close
,
Brett G Hollier Institute of Health and Biomedical Innovation, Vancouver Prostate Centre, Departments of Medicine and Oncology, Australian Prostate Cancer Research Centre – Queensland, Princess Alexandra Hospital, Queensland University of Technology, Level 1, Building 1, 199 Ipswich Road, Brisbane, Queensland 4102, Australia

Search for other papers by Brett G Hollier in
Google Scholar
PubMed
Close
,
Susan Ettinger Institute of Health and Biomedical Innovation, Vancouver Prostate Centre, Departments of Medicine and Oncology, Australian Prostate Cancer Research Centre – Queensland, Princess Alexandra Hospital, Queensland University of Technology, Level 1, Building 1, 199 Ipswich Road, Brisbane, Queensland 4102, Australia

Search for other papers by Susan Ettinger in
Google Scholar
PubMed
Close
,
Ladan Fazli Institute of Health and Biomedical Innovation, Vancouver Prostate Centre, Departments of Medicine and Oncology, Australian Prostate Cancer Research Centre – Queensland, Princess Alexandra Hospital, Queensland University of Technology, Level 1, Building 1, 199 Ipswich Road, Brisbane, Queensland 4102, Australia

Search for other papers by Ladan Fazli in
Google Scholar
PubMed
Close
,
Nataly Stylianou Institute of Health and Biomedical Innovation, Vancouver Prostate Centre, Departments of Medicine and Oncology, Australian Prostate Cancer Research Centre – Queensland, Princess Alexandra Hospital, Queensland University of Technology, Level 1, Building 1, 199 Ipswich Road, Brisbane, Queensland 4102, Australia

Search for other papers by Nataly Stylianou in
Google Scholar
PubMed
Close
,
Stephen C Hendy Institute of Health and Biomedical Innovation, Vancouver Prostate Centre, Departments of Medicine and Oncology, Australian Prostate Cancer Research Centre – Queensland, Princess Alexandra Hospital, Queensland University of Technology, Level 1, Building 1, 199 Ipswich Road, Brisbane, Queensland 4102, Australia

Search for other papers by Stephen C Hendy in
Google Scholar
PubMed
Close
,
Hans H Adomat Institute of Health and Biomedical Innovation, Vancouver Prostate Centre, Departments of Medicine and Oncology, Australian Prostate Cancer Research Centre – Queensland, Princess Alexandra Hospital, Queensland University of Technology, Level 1, Building 1, 199 Ipswich Road, Brisbane, Queensland 4102, Australia

Search for other papers by Hans H Adomat in
Google Scholar
PubMed
Close
,
Martin E Gleave Institute of Health and Biomedical Innovation, Vancouver Prostate Centre, Departments of Medicine and Oncology, Australian Prostate Cancer Research Centre – Queensland, Princess Alexandra Hospital, Queensland University of Technology, Level 1, Building 1, 199 Ipswich Road, Brisbane, Queensland 4102, Australia

Search for other papers by Martin E Gleave in
Google Scholar
PubMed
Close
,
Michael Pollak Institute of Health and Biomedical Innovation, Vancouver Prostate Centre, Departments of Medicine and Oncology, Australian Prostate Cancer Research Centre – Queensland, Princess Alexandra Hospital, Queensland University of Technology, Level 1, Building 1, 199 Ipswich Road, Brisbane, Queensland 4102, Australia

Search for other papers by Michael Pollak in
Google Scholar
PubMed
Close
,
Adrian Herington Institute of Health and Biomedical Innovation, Vancouver Prostate Centre, Departments of Medicine and Oncology, Australian Prostate Cancer Research Centre – Queensland, Princess Alexandra Hospital, Queensland University of Technology, Level 1, Building 1, 199 Ipswich Road, Brisbane, Queensland 4102, Australia

Search for other papers by Adrian Herington in
Google Scholar
PubMed
Close
, and
Colleen C Nelson Institute of Health and Biomedical Innovation, Vancouver Prostate Centre, Departments of Medicine and Oncology, Australian Prostate Cancer Research Centre – Queensland, Princess Alexandra Hospital, Queensland University of Technology, Level 1, Building 1, 199 Ipswich Road, Brisbane, Queensland 4102, Australia
Institute of Health and Biomedical Innovation, Vancouver Prostate Centre, Departments of Medicine and Oncology, Australian Prostate Cancer Research Centre – Queensland, Princess Alexandra Hospital, Queensland University of Technology, Level 1, Building 1, 199 Ipswich Road, Brisbane, Queensland 4102, Australia

Search for other papers by Colleen C Nelson in
Google Scholar
PubMed
Close

factors insulin and IGF1 have been implicated in prostate cancer (PC) progression ( Pollak 2008 a , Lubik et al . 2011 ); however, the role of IGF2 is less well explored. IGF2 expression is elevated in ovarian, colorectal and breast cancer associated

Free access
Tanya K Day
Search for other papers by Tanya K Day in
Google Scholar
PubMed
Close
and
Tina Bianco-Miotto Dame Roma Mitchell Cancer Research Laboratories, School of Paediatrics and Reproductive Health, School of Agriculture, Discipline of Medicine, Hanson Institute, Adelaide Prostate Cancer Research Centre, The University of Adelaide, Adelaide, South Australia, Australia
Dame Roma Mitchell Cancer Research Laboratories, School of Paediatrics and Reproductive Health, School of Agriculture, Discipline of Medicine, Hanson Institute, Adelaide Prostate Cancer Research Centre, The University of Adelaide, Adelaide, South Australia, Australia

Search for other papers by Tina Bianco-Miotto in
Google Scholar
PubMed
Close

Introduction Numerous diseases are associated with abnormal hormonal regulation including breast and prostate cancers. Breast cancer is a heterogeneous disease that can be classified in many ways. The most primary classification is by hormone

Free access
Stefan J Barfeld Prostate Cancer Research Group Centre for Molecular Medicine Norway (NCMM), Nordic EMBL Partnership, University of Oslo and Oslo University Hospital, N-0318 Oslo, Norway

Department of Cancer Prevention Institute of Cancer Research

Department of Urology Oslo University Hospital, N-0424 Oslo, Norway

Search for other papers by Stefan J Barfeld in
Google Scholar
PubMed
Close
,
Harri M Itkonen Prostate Cancer Research Group Centre for Molecular Medicine Norway (NCMM), Nordic EMBL Partnership, University of Oslo and Oslo University Hospital, N-0318 Oslo, Norway

Department of Cancer Prevention Institute of Cancer Research

Department of Urology Oslo University Hospital, N-0424 Oslo, Norway

Search for other papers by Harri M Itkonen in
Google Scholar
PubMed
Close
,
Alfonso Urbanucci Prostate Cancer Research Group Centre for Molecular Medicine Norway (NCMM), Nordic EMBL Partnership, University of Oslo and Oslo University Hospital, N-0318 Oslo, Norway

Department of Cancer Prevention Institute of Cancer Research

Department of Urology Oslo University Hospital, N-0424 Oslo, Norway

Search for other papers by Alfonso Urbanucci in
Google Scholar
PubMed
Close
, and
Ian G Mills Prostate Cancer Research Group Centre for Molecular Medicine Norway (NCMM), Nordic EMBL Partnership, University of Oslo and Oslo University Hospital, N-0318 Oslo, Norway

Department of Cancer Prevention Institute of Cancer Research

Department of Urology Oslo University Hospital, N-0424 Oslo, Norway
Prostate Cancer Research Group Centre for Molecular Medicine Norway (NCMM), Nordic EMBL Partnership, University of Oslo and Oslo University Hospital, N-0318 Oslo, Norway

Department of Cancer Prevention Institute of Cancer Research

Department of Urology Oslo University Hospital, N-0424 Oslo, Norway
Prostate Cancer Research Group Centre for Molecular Medicine Norway (NCMM), Nordic EMBL Partnership, University of Oslo and Oslo University Hospital, N-0318 Oslo, Norway

Department of Cancer Prevention Institute of Cancer Research

Department of Urology Oslo University Hospital, N-0424 Oslo, Norway

Search for other papers by Ian G Mills in
Google Scholar
PubMed
Close

) ( DeBerardinis et al . 2008 ). It is therefore not surprising that metabolic adaptations have been reported in various human cancers ( Hsu & Sabatini 2008 ). Metabolic status of the prostate gland and cancer predisposition The prostate gland is principally

Free access